3/26
04:05 pm
huma
Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024
Medium
Report
Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024
3/26
08:40 am
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $4.00 price target on the stock.
Medium
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $4.00 price target on the stock.
3/25
11:29 am
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
Low
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
3/23
10:23 am
huma
Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/22
07:24 am
huma
Humacyte GAAP EPS of -$0.24 in-line [Seeking Alpha]
Medium
Report
Humacyte GAAP EPS of -$0.24 in-line [Seeking Alpha]
3/22
07:10 am
huma
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update [Yahoo! Finance]
High
Report
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update [Yahoo! Finance]
3/22
07:00 am
huma
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
High
Report
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
3/19
11:00 am
huma
Should You Buy Humacyte (HUMA) Ahead of Earnings? [Yahoo! Finance]
Low
Report
Should You Buy Humacyte (HUMA) Ahead of Earnings? [Yahoo! Finance]
3/18
08:17 am
huma
Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024 [Yahoo! Finance]
Medium
Report
Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024 [Yahoo! Finance]
3/18
08:00 am
huma
Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024
Medium
Report
Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024
3/4
12:20 pm
huma
Humacyte Shares Rise 10% on Common Stock Offering [MarketWatch]
Neutral
Report
Humacyte Shares Rise 10% on Common Stock Offering [MarketWatch]
3/1
09:16 am
huma
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference
Medium
Report
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference
3/1
05:12 am
huma
Humacyte stock dips after pricing stock offering to raise $40.2M [Seeking Alpha]
Low
Report
Humacyte stock dips after pricing stock offering to raise $40.2M [Seeking Alpha]
2/29
09:18 pm
huma
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock
High
Report
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock
2/29
06:48 pm
huma
Humacyte Shares Drop 19% After Proposed Public Offering News [MarketWatch]
High
Report
Humacyte Shares Drop 19% After Proposed Public Offering News [MarketWatch]
2/29
05:17 pm
huma
ADSK, NTAP and RILY are among after hour movers [Seeking Alpha]
High
Report
ADSK, NTAP and RILY are among after hour movers [Seeking Alpha]
2/29
04:13 pm
huma
Humacyte, Inc. Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
High
Report
Humacyte, Inc. Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
2/29
04:01 pm
huma
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
High
Report
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
2/26
06:15 am
huma
Here's Why We're Watching Humacyte's (NASDAQ:HUMA) Cash Burn Situation [Yahoo! Finance]
Medium
Report
Here's Why We're Watching Humacyte's (NASDAQ:HUMA) Cash Burn Situation [Yahoo! Finance]
2/12
11:10 am
huma
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma [Yahoo! Finance]
Low
Report
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma [Yahoo! Finance]
2/9
08:20 am
huma
Humacyte Gets Speedy FDA Review of Bioengineered Tissue in Vascular Trauma [MarketWatch]
Medium
Report
Humacyte Gets Speedy FDA Review of Bioengineered Tissue in Vascular Trauma [MarketWatch]
2/9
08:14 am
huma
Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma [Yahoo! Finance]
High
Report
Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma [Yahoo! Finance]
2/9
08:00 am
huma
Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
High
Report
Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
1/16
09:11 am
huma
Humacyte, Inc.'s (NASDAQ:HUMA) largest shareholders are retail investors with 48% ownership, public companies own 18% [Yahoo! Finance]
Neutral
Report
Humacyte, Inc.'s (NASDAQ:HUMA) largest shareholders are retail investors with 48% ownership, public companies own 18% [Yahoo! Finance]